These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26906549)

  • 1. AMP-activated protein kinase and its multifaceted regulation of hepatic metabolism.
    Fullerton MD
    Curr Opin Lipidol; 2016 Apr; 27(2):172-80. PubMed ID: 26906549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
    Viollet B; Guigas B; Leclerc J; Hébrard S; Lantier L; Mounier R; Andreelli F; Foretz M
    Acta Physiol (Oxf); 2009 May; 196(1):81-98. PubMed ID: 19245656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
    Guigas B; Viollet B
    Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK: an emerging drug target for diabetes and the metabolic syndrome.
    Zhang BB; Zhou G; Li C
    Cell Metab; 2009 May; 9(5):407-16. PubMed ID: 19416711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP-activated protein kinase: Role in metabolism and therapeutic implications.
    Schimmack G; Defronzo RA; Musi N
    Diabetes Obes Metab; 2006 Nov; 8(6):591-602. PubMed ID: 17026483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
    Musi N; Goodyear LJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK: guardian of metabolism and mitochondrial homeostasis.
    Herzig S; Shaw RJ
    Nat Rev Mol Cell Biol; 2018 Feb; 19(2):121-135. PubMed ID: 28974774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
    Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
    J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AMPK as a cellular energy sensor and its function in the organism].
    Miranda N; Tovar AR; Palacios B; Torres N
    Rev Invest Clin; 2007; 59(6):458-69. PubMed ID: 18402338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
    Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase pathway and bone metabolism.
    Jeyabalan J; Shah M; Viollet B; Chenu C
    J Endocrinol; 2012 Mar; 212(3):277-90. PubMed ID: 21903861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.
    Zheng T; Yang X; Wu D; Xing S; Bian F; Li W; Chi J; Bai X; Wu G; Chen X; Zhang Y; Jin S
    Br J Pharmacol; 2015 Jul; 172(13):3284-301. PubMed ID: 25754463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the mechanisms of metformin action in the liver.
    Viollet B; Foretz M
    Ann Endocrinol (Paris); 2013 May; 74(2):123-9. PubMed ID: 23582849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
    Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
    Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
    Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK and autophagy in glucose/glycogen metabolism.
    Ha J; Guan KL; Kim J
    Mol Aspects Med; 2015 Dec; 46():46-62. PubMed ID: 26297963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation.
    Krishan S; Richardson DR; Sahni S
    Mol Pharmacol; 2015; 87(3):363-77. PubMed ID: 25422142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting AMPK in Diabetes and Diabetic Complications: Energy Homeostasis, Autophagy and Mitochondrial Health.
    Madhavi YV; Gaikwad N; Yerra VG; Kalvala AK; Nanduri S; Kumar A
    Curr Med Chem; 2019; 26(27):5207-5229. PubMed ID: 29623826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.